AstraZeneca’s Heart Drug Brilique Gets Final OK From Germany

AstraZeneca’s key heart drug Brilique has won a final recommendation from medical evaluation authorities in Germany under the country’s new, and more rigorous, drug pricing regime.
The Wall Street Journal